# Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh

> **NCT03890497** · PHASE4 · UNKNOWN · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 300 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** IPV

## Key facts

- **NCT ID:** NCT03890497
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-27
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03890497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03890497, "Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03890497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*